Valuation: Cellink AB

Market Cap 1.03B 108M 93.85M 87.15M 80.38M 151M 10.32B 154M 404M 5.12B 406M 397M 17.23B P/E 2026 *
-6.43x
P/E 2027 * -9.19x
Enterprise Value 1.04B 109M 94.67M 87.91M 81.08M 153M 10.41B 155M 408M 5.17B 409M 400M 17.38B EV / Sales 2026 *
0.59x
EV / Sales 2027 * 0.53x
Free-Float
68.5%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 54 27/11/2023
Director of Finance/CFO 56 01/03/2026
Chief Operating Officer - 07/01/2026
Director TitleAgeSince
Director/Board Member 70 18/12/2019
Director/Board Member 65 08/05/2025
Chairman 51 16/09/2025
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 106M
-0.79%-0.03%+19.88%+4.28% 214B
-0.36%+1.70%-4.03%-23.25% 138B
-0.87%+5.34%-30.12%+7.82% 125B
-1.28%+4.05%-57.48%-12.46% 68.43B
+0.45%+2.82%+6.19%+5.01% 49.38B
-0.91%+9.32%-24.83%-29.57% 47.55B
-1.36%-1.01%+17.17%+13.60% 39.63B
-0.28%-1.09%+26.47%+36.93% 37.26B
-3.84%+11.25%-3.62%-11.47% 32.71B
Average -0.90%+7.11%-5.60%-1.01% 83.56B
Weighted average by Cap. -0.82%+7.53%-4.41%-2.38%

Financials

2026 *2027 *
Net sales 1.76B 185M 160M 149M 137M 259M 17.64B 264M 691M 8.76B 694M 679M 29.46B 1.9B 199M 173M 160M 148M 279M 18.98B 284M 743M 9.43B 747M 730M 31.7B
Net income -162M -17M -14.77M -13.72M -12.65M -23.83M -1.62B -24.26M -63.58M -806M -63.86M -62.46M -2.71B -112M -11.75M -10.21M -9.48M -8.74M -16.46M -1.12B -16.76M -43.93M -557M -44.12M -43.16M -1.87B
Net Debt 9M 942K 819K 760K 701K 1.32M 89.98M 1.34M 3.52M 44.69M 3.54M 3.46M 150M -20M -2.09M -1.82M -1.69M -1.56M -2.93M -200M -2.99M -7.83M -99.31M -7.87M -7.69M -334M
Logo Cellink AB
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-